Skip to main content
. 2020 Oct 9;142(22):2095–2106. doi: 10.1161/CIRCULATIONAHA.120.048792

Figure 5.

Figure 5.

Association between ECMELLA use and intervention because of access site–related ischemia in prespecified subgroups. P interaction is 0.75 for age <52 years versus age 52 to 62 years, 0.95 for age <52 years versus age >62 years, and 0.82 for age 52 to 62 years versus age >62 years. P interaction is 0.62 for lactate <5 mmol/L versus 5 to 10.8 mmol/L, 0.52 for <5 mmol/L versus >10.8 mmol/L, and 0.23 for 5 to 10.8 mmol/L versus >10.8 mmol/L. P interaction is 0.58 for survival after venoarterial extracorporeal membrane oxygenation (SAVE) score >−6 versus −6 to −11, 0.51 for >−6 versus <−11, and 0.23 for −6 to −11 versus <−11. P interaction is 0.65 for Simplified Acute Physiology Score II (SAPS II) <52 versus −52 to 76, 0.64 for <52 versus >76, and 0.31 for 52 to 76 versus >76. AMI indicates acute myocardial infarction; CS, cardiogenic shock; ECMELLA, Impella+extracorporeal membrane oxygenation; eCPR, venoarterial extracorporeal membrane oxygenation–assisted cardiopulmonary resuscitation; NS, nonsignificant; OR, odds ratio; and VA-ECMO, venoarterial extracorporeal membrane oxygenation.